Scarica l'app Stockscreener
31.88
3.17%
0.98
Dopo l'orario di chiusura:
31.88
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BAX Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Baxter International Inc Borsa (BAX) Ultime notizie
Ameriprise Financial Inc. Sells 2,346,164 Shares of Baxter International Inc. (NYSE:BAX) - MarketBeat
Morgan Stanley Has Lowered Expectations for Baxter International (NYSE:BAX) Stock Price - MarketBeat
Baxter International Inc. (BAX) Announces Results of 2025 Annual Meeting - GuruFocus
Baxter International Holds 2025 Annual Meeting with Key Decisions - TipRanks
Baxter International Inc (BAX) Shares Up 4.23% on May 8 - GuruFocus
The 'Goldilocks' Case For Baxter International (NYSE:BAX) - Seeking Alpha
SHAREHOLDER ALERT: Potential Recovery for Baxter International Inc. (BAX) Investors Affected by Stock DropLevi & Korsinsky Pursuing Class Action Lawsuit - ACCESS Newswire
Baxter International First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Beyond the Balance Sheet: What SWOT Reveals About Baxter Interna - GuruFocus
Baxter International IncDeclares Quarterly Dividend Of $0.17 Per Share - marketscreener.com
Baxter Declares Quarterly Dividend | BAX Stock News - GuruFocus
Baxter Declares Quarterly Dividend - Bluefield Daily Telegraph
Hurricane Helene impact on Baxter to further limit IV fluid supply, HHS says - AOL.com
What Are Wall Street Analysts' Target Price For Baxter International Stock? - Barchart.com
What Are Wall Street Analysts' Target Price for Baxter International Stock? - inkl
Analysts Offer Insights on Healthcare Companies: Baxter International (BAX) and Vera Therapeutics (VERA) - The Globe and Mail
Baxter stock rises on earnings beat, guidance raise - MSN
Baxter International Inc. (NYSE:BAX) Q1 2025 Earnings Call Transcript - Insider Monkey
Health care company says Trump tariffs will cost it $60M–$70M this year - Ars Technica
Baxter International Inc. (NYSE:BAX) Shares Sold by Banco Bilbao Vizcaya Argentaria S.A. - MarketBeat
Baxter Intl (BAX): Wells Fargo Lowers Price Target to $33 | BAX Stock News - GuruFocus
Baxter (BAX) Target Price Reduced by Stifel Amid Strong Q1 Results | BAX Stock News - GuruFocus
Wells Fargo Adjusts Baxter International Price Target to $33 From $36 - marketscreener.com
Citigroup Adjusts Price Target on Baxter International to $34 From $35 - marketscreener.com
JPMorgan Adjusts Price Target on Baxter International to $34 From $36 - marketscreener.com
Here's Why Baxter International (NYSE:BAX) Has A Meaningful Debt Burden - simplywall.st
Press Release Distribution & PR Platform - ACCESS Newswire
Baxter International Inc (BAX) Q1 2025 Earnings Call Highlights: Strong Sales Growth and EPS ... - Yahoo
Baxter International Inc (BAX) Q1 2025 Earnings Call Highlights: Strong Sales Growth and EPS Surpass Expectations - GuruFocus
Baxter International Reports Strong Q1 2025 Results - TipRanks
State of Tennessee Department of Treasury Sells 69,945 Shares of Baxter International Inc. (NYSE:BAX) - MarketBeat
Baxter International Surpasses Q1 2025 Expectations - TipRanks
Baxter International, Deerfield-based maker of IV fluid and pharmaceuticals, expects tariff impact of $60 to $70M - Chicago Tribune
Balanced Outlook on Baxter International: Strong Performance with Margin Concerns - TipRanks
Baxter International Inc. 2025 Q1ResultsEarnings Call Presentation (NYSE:BAX) - Seeking Alpha
Baxter Earnings: Elevated Medical Utilization Mildly Boosts 2025 Outlook Despite Tariff Concerns - Morningstar
Baxter Still in Turnaround Mode Following Weak Postpandemic Results and Renal Divestiture - Morningstar
Evercore ISI Adjusts Baxter International Price Target to $44 From $45, Maintains Outperform Rating - marketscreener.com
Baxter International (BAX) Stock Climbs on Strong Earnings and R - GuruFocus
BAX Stock Gains Following Q1 Earnings Beat Estimates, Revenues Up Y/Y - TradingView
Baxter Reports Strong Medical Devices Sales In Q1, Lifts 2025 Guidance, Stock Jumps - Benzinga
Baxter stock rises on earnings beat, guidance raise (BAX:NYSE) - Seeking Alpha
Baxter International Surpasses Revenue Expectations in Q1 2025News and Statistics - IndexBox
Earnings call transcript: Baxter International beats Q1 2025 expectations - Investing.com
Earnings call transcript: Baxter International beats Q1 2025 expectations By Investing.com - Investing.com India
Baxter’s (NYSE:BAX) Q1: Beats On Revenue - Yahoo Finance
Baxter (BAX) Reports Q1 Earnings: What Key Metrics Have to Say - Yahoo Finance
Baxter posts strong U.S. sales, anticipates $60M hit from tariffs - Crain's Chicago Business
Baxter (BAX) Surpasses Q1 Revenue Forecast Amid Strategic Transf - GuruFocus
Baxter (BAX) Updates Sales and Earnings Outlook | BAX Stock News - GuruFocus
Baxter tops quarterly estimates on strong demand for medical devices - TradingView
Baxter International's Q1 Adjusted Net Income Drops, Revenue Rises; Full-Year 2025 Guidance Revised - marketscreener.com
Baxter Q1 2025 slides: Sales beat expectations, EPS surges 53%, guidance raised - Investing.com Australia
Baxter International Inc Surpasses Q1 2025 Estimates with $0.55 EPS and $2.63 Billion Revenue - GuruFocus
Baxter Reports First-Quarter 2025 Results - Baxter
Baxter Reports First-Quarter 2025 Results | BAX Stock News - GuruFocus
Baxter International Boosts FY25 OutlookUpdate - Nasdaq
3.00%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):